Bile duct patency maintained after intraductal radiofrequency ablation in a case of hepatocellular cholangiocarcinoma with bile duct invasion

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Combined hepatocellular-cholangiocarcinoma (HCC-CC) with bile duct invasion (BDI) is rare. In unresectable cases, biliary stent placement and photodynamic therapy (PDT) are used for resolving obstructive jaundice. However, stent occlusion remains problematic, and PDT is expensive and time-consuming. Intraductal radiofrequency ablation (RFA) is an emerging procedure for palliation in these patients. It has potential benefits including less expense, lower rates of severe complication, longer maintenance of ductal patency, and easier technique compared with PDT or stenting alone. We report a 67-year-old man who underwent repeated intraductal RFA for HCC-CC and HCC with BDI, for whom bile duct patency was maintained without additional biliary procedures.

Cite

CITATION STYLE

APA

Han, S. Y., Song, G. A., Kim, D. U., Baek, D. H., Lee, M. W., & Kim, G. H. (2018). Bile duct patency maintained after intraductal radiofrequency ablation in a case of hepatocellular cholangiocarcinoma with bile duct invasion. Clinical Endoscopy, 51(2), 201–205. https://doi.org/10.5946/ce.2017.097

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free